Ceribell, INC. 8-K Filing
Ticker: CBLL · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1861107
| Field | Detail |
|---|---|
| Company | Ceribell, INC. (CBLL) |
| Form Type | 8-K |
| Filed Date | Nov 24, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Ceribell, INC. (ticker: CBLL) to the SEC on Nov 24, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (nge on which registered Common stock, $0.001 par value per share CBLL Nasdaq Glo).
How long is this filing?
Ceribell, INC.'s 8-K filing is 1 pages with approximately 424 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 424 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2025-11-24 08:16:40
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value per share CBLL Nasdaq Glo
Filing Documents
- cbll-20251124.htm (8-K) — 46KB
- cbll-ex99_1.htm (EX-99.1) — 23KB
- img260468198_0.jpg (GRAPHIC) — 18KB
- 0001193125-25-292140.txt ( ) — 204KB
- cbll-20251124.xsd (EX-101.SCH) — 24KB
- cbll-20251124_htm.xml (XML) — 5KB
01
Item 8.01 Other Events. On November 24, 2025, Ceribell, Inc. ("Ceribell") issued a press release announcing that the U.S. Food and Drug Administration ("FDA") granted 510(k) clearance for Ceribell's Clarity algorithm for detecting electrographic seizures in newborns preterm and older. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated November 24, 2025. 104 Cover Page Interactive Data File, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CERIBELL, INC. Date: November 24, 2025 By: /s/ Scott Blumberg Scott Blumberg Chief Financial Officer